Breaking News
December 12, 2017 - CAR T cell therapy shows long-lasting remissions in non-Hodgkin’s lymphoma patients
December 12, 2017 - Live-cell microscopy reveals internal forces that direct cell migration
December 12, 2017 - GSK Submits US Regulatory Application for Single-Dose Tafenoquine for Plasmodium vivax Malaria
December 12, 2017 - High Blood Urea Nitrogen Levels Tied to T2D Risk
December 12, 2017 - Blood Smear: MedlinePlus Lab Test Information
December 12, 2017 - Atopic eczema—one size does not fit all
December 12, 2017 - Biological Applications of AFM
December 12, 2017 - Study provides new insights into mechanism of tumor survival in glioblastoma
December 12, 2017 - FDA Approves Admelog (insulin lispro) Short-Acting “Follow-On” Insulin Product to Treat Diabetes
December 12, 2017 - Chromosomes Fact Sheet – National Human Genome Research Institute (NHGRI)
December 12, 2017 - Discovery puts the brakes on HIV’s ability to infect
December 12, 2017 - Researchers uncover novel strategy to program immune system for fighting cancer
December 12, 2017 - Study finds under-age marriage for women as marker of multiple vulnerabilities
December 12, 2017 - Scientists discover specific mechanism of Zika virus-associated microcephaly
December 12, 2017 - Creating Your Family Health Tree
December 12, 2017 - Biological Pathways Fact Sheet – National Human Genome Research Institute (NHGRI)
December 12, 2017 - LSUHealthNO breakthrough may pave way for advances in obesity-related diseases
December 12, 2017 - Few people with HIV get prompt care after incarceration
December 11, 2017 - Air pollution exposure before or after conception linked to increased risk of birth defects in children
December 11, 2017 - Abu Dhabi focuses on reducing childhood obesity
December 11, 2017 - Employees with influenza have more lost work time
December 11, 2017 - type 2 diabetes – Genetics Home Reference
December 11, 2017 - Insufficient evidence to guide recommendations on vitamin D in pregnancy
December 11, 2017 - St. Jude gene therapy offers hope for infants with ‘bubble boy’ disease
December 11, 2017 - Soy foods, cruciferous vegetables may reduce breast cancer treatment’s side effects
December 11, 2017 - Nearly 3 in 10 elite footballers at top clubs have undetected lung and airway problems, study finds
December 11, 2017 - Why some workers can’t call it quits
December 11, 2017 - Healthier Diet, Less Salt: The Recipe to Beat High Blood Pressure: MedlinePlus Health News
December 11, 2017 - Research leads to call for lung health screening at top football clubs
December 11, 2017 - Drug improves disease-free, overall survival after hematopoietic stem cell transplants
December 11, 2017 - Researchers generate 3D cell cultures to investigate mechanisms of drug resistance in breast cancer
December 11, 2017 - New, more easily administered therapies offer benefits for bleeding and clotting disorders
December 11, 2017 - Opioids after surgery left her addicted. Is that a medical error?
December 11, 2017 - Scientists develop software that predicts leukemia-specific immune targets
December 11, 2017 - Does Your Pet Have a Weight Problem? Here’s How to Tell: MedlinePlus Health News
December 11, 2017 - Genetic variant prompts cells to store fat, fueling obesity
December 11, 2017 - Canola oil linked to worsening of Alzheimer’s
December 11, 2017 - New Breast Cancer Drug Ribociclib (Kisqali) May Benefit Younger Women, Too
December 11, 2017 - Healthy Living May Ease Some MS Symptoms: MedlinePlus Health News
December 11, 2017 - Researchers develop a molecular taxonomy for hair disorders
December 11, 2017 - Study shows safety, efficacy of cystic fibrosis drug in children between 1 to 2 years of age
December 11, 2017 - Two immunotherapy approaches for multiple myeloma show hope
December 11, 2017 - The Valley Hospital uses novel mobile app to enhance pre-hospital emergency care
December 11, 2017 - ‘I Entered Medical School Through a Hunger Strike’: What We Heard This Week
December 11, 2017 - Research team unlocks secrets of Ebola
December 11, 2017 - Generic versions of Viagra coming this week
December 11, 2017 - New genetic model identified for predicting outcomes in patients with primary myelofibrosis
December 11, 2017 - Research shows that e-cigarettes serve as gateway to traditional smoking
December 11, 2017 - A risk factor for drug-induced skin disease identified
December 11, 2017 - MIT researchers discover new way to make bacteria vulnerable to existing antibiotics
December 11, 2017 - Dengue vaccine issues in the Philippines
December 11, 2017 - Office Workers Don’t Like Being Chained to Their Desks: MedlinePlus Health News
December 11, 2017 - Study reveals how a very low calorie diet can reverse type 2 diabetes
December 11, 2017 - Study highlights potential for reducing greenhouse gas emissions in health care settings
December 11, 2017 - University of Adelaide receives $23.2 million for preterm birth research
December 11, 2017 - Tough Flu Season Ahead: Vaccine May Only Be 10% Effective
December 11, 2017 - Getting Self-Driving Cars on the Road Soon Might Save Lives: MedlinePlus Health News
December 11, 2017 - Enterovirus vaccine prevents virus-induced diabetes in a T1D experimental model
December 11, 2017 - Solar retinopathy or sun damage to the eyes – a case report
December 11, 2017 - Cancer risk with birth control pills emerges again in latest study
December 10, 2017 - Deer Hunters: Put Safety First: MedlinePlus Health News
December 10, 2017 - High blood pressure is redefined as 130, not 140: US guidelines (Update)
December 10, 2017 - Unusual neuroinflammation may underlie cognitive problems in cART-treated HIV patients
December 10, 2017 - Racial differences in parents’ reports of child’s autism symptoms may contribute to delayed diagnosis
December 10, 2017 - Taurine could boost effectiveness of existing multiple sclerosis therapies
December 10, 2017 - The man with a young woman’s heart
December 10, 2017 - Patient bedside remains important component of medical education for students
December 10, 2017 - Nutrition labeling has little impact on sodium consumption
December 10, 2017 - ‘Obesity paradox’ not present among people with new cases of cardiovascular disease
December 10, 2017 - SLU scientists provide promising approach in designing new drugs for DMD
December 10, 2017 - Can PD-1 Inhibitor Help Eradicate HIV?
December 10, 2017 - Checking Prices for Medical Procedures Online? Good Luck: MedlinePlus Health News
December 10, 2017 - Researchers find bacteria tied to esophageal cancer
December 10, 2017 - Boy’s Double Hand Transplant Changed His Brain
December 10, 2017 - Memo to Doctors: Spit Out the Bad News: MedlinePlus Health News
December 10, 2017 - Two years of extended anastrozole therapy proved as effective as five years in clinical trial
December 10, 2017 - Using digital devices before bed may contribute to sleep and nutrition problems in children
December 10, 2017 - Are You Sure That’s What the Doctor Said About Your Leukemia?: MedlinePlus Health News
December 10, 2017 - Low vitamin D levels at birth linked to higher autism risk
December 10, 2017 - Alcohol use in movies influences onset of drinking among 10- to 15-year-olds
New HIV prevention guidelines from Canada released

New HIV prevention guidelines from Canada released

image_pdfDownload PDFimage_print

New guidelines for Canada have been published in the Canadian Medical Association Journal online this week that outline the use of new anti-HIV medications among high risk populations who are at risk of contracting HIV from getting the dreaded infection. These new guidelines aim to provide the clinicians with resources and support he added.

This research was funded by the Canadian Institutes of Health Research and the Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network.

The guidelines outline the use of these medications both before and after exposure to HIV infection. These are called pre-exposure prophylaxis, or PrEP, and non-occupational post-exposure prophylaxis, and nPEP respectively. PrEP refers to use of antiretroviral drugs regularly before an exposure to the infection occurs.

This is suitable for persons who are at risk of getting HIV infections such as those who work with HIV positive individuals and also sexual partners of HIV positive individuals. nPEP refers to a course of anti HIV medications that are given to persons who have been exposed to HIV infection either sexually or due to drug-use related causes to prevent the infection.

The guidelines that have been released suggest that these are biomedical interventions that must be part of a combination of preventive strategies adopted for HIV prevention and control. Behavioral interventions to prevent HIV infection include use of condoms and safe sex practices and adopting other measures to protect oneself from HIV exposure.

Dr. Darrell Tan, an infectious disease physician and scientist at St. Michael’s Hospital and lead author of the guidelines said in his statement, “There are new biomedical HIV prevention strategies that have been widely endorsed worldwide by organizations including the WHO, U.S. CDC and others…In particular, PrEP is a highly effective and safe Health Canada-approved method that involves taking a daily pill, which, if taken properly, can offer almost 100 per cent protection against new HIV infection.” Dr. Tan was part of the 25 member panel that worked together with the Biomedical HIV Prevention Working Group of the CIHR’s Canadian HIV Trials Network. The screened through all the available literature on the benefits provided by the PrEP and nPEP regimens.

The authors add that HIV incidence in Canada is still high and cause for concern and these guidelines come in as very important in this scenario. They write that homosexual men in Canada are 131 times more at risk of getting HIV infection compared to heterosexual men and 54 percent of the new HIV infections are seen among homosexual men. Similarly those who are injection drug users are 59 times more likely to contractHIV compared to those who are non-users. Indigenous people are 2.7 times more likely to get HIV and those who have immigrated from countries that have endemic HIV infections are 6.4 times more likely to get this infection, the report adds.

PrEP now has been recommended for:

  • men who have sex with men (MSM)
  • transgender women who had anal sex without a condom in the previous 6 months along with criteria such as;
    • Presence of syphilis or bacterial STD of the rectum
    • Past use of nPEP more than once
    • Ongoing relationship with a HIV positive individual
    • MSM HIV risk index (a measure for risk) over 10
  • Heterosexuals who had condomless vaginal or anal sex with someone who has HIV
  • Drug users who share injection paraphernalia

Drugs for PrEP include once-daily tenofovir disoproxil fumarate with emtricitabine (TDF/FTC).

The guidelines recommend nPEP in patients presenting within 72 hours of moderate or high-risk exposure to HIV. The regimens include TDF/FTC along with either raltegravir, dolutegravir or a combination of darunavir and ritonavir.

The authors performed an economic analysis assessing the cost benefit aspects of PrEP and nPEP in HIV prevention. Dr. Tan explained that the cost of these antiretroviral drugs has been the major obstacle that has “restricted the feasibility and acceptability” of these interventions. With the introduction of the generic versions of these medications and also availability of these drugs for public use, PrEP in Canada may now have a good run providing cost effective benefits. These guidelines are in the same lines as those already in place in the United Kingdom, the United States and Australia.

Dr. Tan hopes that introduction of PrEP can dramatically reduce the number of new cases as has been seen in other countries.

Source:

http://www.cmaj.ca/content/189/47/E1448

Tagged with:

About author

Related Articles